Tibor Gajdics
Direktor/Vorstandsmitglied bei GOLDEN AGE EXPLORATION LTD.
Vermögen: 48 501 $ am 31.05.2024
Aktive Beziehungen
| Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
|---|---|---|---|---|
| Kevin Hanson | M | 67 | 8 Jahre | |
| Ian Hollis Mann | M | 66 |
KOP Therapeutics Corp.
 KOP Therapeutics Corp. BiotechnologyHealth Technology KOP Therapeutics Corp. operates as a biotechnology company which focuses on the validation and commercialization of its newly discovered genomic drug platform. The company was founded in 2018 and is headquartered in Vancouver, Canada. | 12 Jahre |
| Angela Holowaychuk | F | 41 | 6 Jahre | |
| Mark Redcliffe | M | - |
KOP Therapeutics Corp.
KOP Therapeutics Corp. BiotechnologyHealth Technology KOP Therapeutics Corp. operates as a biotechnology company which focuses on the validation and commercialization of its newly discovered genomic drug platform. The company was founded in 2018 and is headquartered in Vancouver, Canada. | - |
| Ehsan Salmabadi | M | 41 | 2 Jahre | |
| Aziz-Ur Rehman | M | 51 |
KOP Therapeutics Corp.
KOP Therapeutics Corp. BiotechnologyHealth Technology KOP Therapeutics Corp. operates as a biotechnology company which focuses on the validation and commercialization of its newly discovered genomic drug platform. The company was founded in 2018 and is headquartered in Vancouver, Canada. | 3 Jahre |
| Marco Strub | M | 68 |
KOP Therapeutics Corp.
KOP Therapeutics Corp. BiotechnologyHealth Technology KOP Therapeutics Corp. operates as a biotechnology company which focuses on the validation and commercialization of its newly discovered genomic drug platform. The company was founded in 2018 and is headquartered in Vancouver, Canada. | - |
| Jakson Inwentash | M | 30 |
KOP Therapeutics Corp.
KOP Therapeutics Corp. BiotechnologyHealth Technology KOP Therapeutics Corp. operates as a biotechnology company which focuses on the validation and commercialization of its newly discovered genomic drug platform. The company was founded in 2018 and is headquartered in Vancouver, Canada. | 2 Jahre |
| Joyce Heinzerling Davis | F | - |
KOP Therapeutics Corp.
KOP Therapeutics Corp. BiotechnologyHealth Technology KOP Therapeutics Corp. operates as a biotechnology company which focuses on the validation and commercialization of its newly discovered genomic drug platform. The company was founded in 2018 and is headquartered in Vancouver, Canada. | 5 Jahre |
Beziehungs-Chart
Beziehungen zu mehreren Unternehmen
Ehemalige Beziehungen
| Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
|---|---|---|---|---|
| Simon Moore | M | - | - | |
| Chrisilios Kyriakou | M | 70 | - | |
| Garry Stock | M | - | 1 Jahre | |
| Garry Stock | M | 56 | 1 Jahre | |
| David Rokoss | M | - | - | |
| Owen C. King | M | - | 1 Jahre | |
| Andrew Wilkins | M | 64 | - | |
| Emma Fairhurst | F | - | - | |
| Rich Wheeless | M | - | - | |
| Peter Wielgosz | M | - | - | |
| Justin Corinella | M | - | 1 Jahre |
Statistik
| Land | Beziehungen | % des Gesamten |
|---|---|---|
| Kanada | 20 | 100,00% |
Alter der Beziehungen
Aktive
Vergangene
Herr
Frau
Aufsichtsräte
Führungskräfte
Ursprung der Beziehungen
- Börse
- Insiders
- Tibor Gajdics
- Persönliches Netzwerk
